Serum-Free Cell Culture: From Art to Science in 25 Years

Date: January 5, 1998 Chart 1, Chart 2, Chart 3 With the prospect of huge profits from pharmaceuticals, serum-free tissue culture has been catapulted from a cottage industry to high technology Think of serum-free media and an image comes to mind of a scientist sitting in front of a stack of tissue culture plates, painstakingly adding a little of this or a little of that to each plate in search of just the right combination. The motivation behind this activity varies-some scientists want to

Written byLaura Defrancesco
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Date: January 5, 1998 Chart 1, Chart 2, Chart 3 With the prospect of huge profits from pharmaceuticals, serum-free tissue culture has been catapulted from a cottage industry to high technology Think of serum-free media and an image comes to mind of a scientist sitting in front of a stack of tissue culture plates, painstakingly adding a little of this or a little of that to each plate in search of just the right combination. The motivation behind this activity varies-some scientists want to study the effects of hormones on target cells in vitro, and to do this, the media need to be hormone- and hence serum-free. Others want to understand how the growth of cells is regulated and are using serum stimulation of growth as a paradigm to gain this understanding. And still others just want to create reproducible and uncomplicated experimental culture systems, not dependent on the vagaries ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies